Population approaches in paediatricsCHATELUT, Etienne.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 575-578, issn 0767-3981, 4 p.Conference Paper

Dose-dependency of pharmacokinetic/pharmacodynamic parameters after intravenous bolus doses of cisatracuriumCHEN, C; YAMAGUCHI, N; VARIN, F et al.British journal of anaesthesia. 2008, Vol 101, Num 6, pp 788-797, issn 0007-0912, 10 p.Article

The influence of weightlessness on pharmacokineticsGANDIA, Peggy; SAIVIN, Sylvie; HOUIN, Georges et al.Fundamental & clinical pharmacology. 2005, Vol 19, Num 6, pp 625-636, issn 0767-3981, 12 p.Article

Structural identifiability of physiologically based pharmacokinetic modelsYATES, James W. T.Journal of pharmacokinetics and pharmacodynamics (Print). 2006, Vol 33, Num 4, pp 421-439, issn 1567-567X, 19 p.Article

Population pharmacokinetic modeling : the importance of informative graphicsETTE, E. I; LUDDEN, T. M.Pharmaceutical research. 1995, Vol 12, Num 12, pp 1845-1855, issn 0724-8741Article

Metabolic Transformation of Sesamol and ex Vivo Effect on 2,2'-Azo-bis(2-amidinopropane)-dihydrochloride-lnduced HemolysisHOU, Yu-Chi; TSAI, Shang-Yuan; LIU, I-Ling et al.Journal of agricultural and food chemistry (Print). 2008, Vol 56, Num 20, pp 9636-9640, issn 0021-8561, 5 p.Article

Direct measurement of nitrous oxide kineticsDRUMMOND, G. B; FISHER, L; PUMPHREY, O et al.British journal of anaesthesia. 2012, Vol 109, Num 5, pp 776-781, issn 0007-0912, 6 p.Article

Drug Delivery Trends in Clinical Trials and Translational Medicine: Evaluation of Pharmacokinetic Properties in Special PopulationsCHIEN, Jenny Y; HO, Rodney J. Y.Journal of pharmaceutical sciences. 2011, Vol 100, Num 1, pp 53-58, issn 0022-3549, 6 p.Article

Drug efficact and drug resistance : Drug efficact and drug resistanceFARDEL, Olivier; JIGOREL, Emilie; LE VEE, Marc et al.Biomedicine & pharmacotherapy. 2005, Vol 59, Num 3, pp 104-114, issn 0753-3322, 11 p.Article

Pharmacokinetics of ¹²⁵I-radiolabelled PEG-hemoglobin SB1LEE, Jiwon; LEE, Junhee; YOON, Sojung et al.Artificial cells, blood substitutes, and biotechnology. 2006, Vol 34, Num 3, pp 277-292, 16 p.Article

Factors affecting pharmacokinetics of monoclonal antibodies: A review articleIZNAGA-ESCOBAR, N; MISHRA, A. K; PEREZ-RODRIGUEZ, R et al.Methods and findings in experimental and clinical pharmacology. 2004, Vol 26, Num 2, pp 123-127, issn 0379-0355, 5 p.Article

Enhancing the bioavailability of resveratrol by combining it with piperine : Resveratrol: Current Status and OutlookJOHNSON, Jeremy J; NIHAL, Minakshi; SIDDIQUI, Imtiaz A et al.Molecular nutrition & food research (Print). 2011, Vol 55, Num 8, pp 1169-1176, issn 1613-4125, 8 p.Article

The interaction of gallium with biological systemsHAYES, R. L.International journal of nuclear medicine & biology. 1983, Vol 10, Num 4, pp 257-261, issn 0047-0740Article

Some considerations on the design of population pharmacokinetic studiesDUFFULL, Stephen; WATERHOUSE, Tim; ECCLESTON, John et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 441-457, issn 1567-567X, 17 p.Article

Pharmacokinetics and tolerability of intranasal diazepam and midazolam in healthy adult volunteersIVATURI, V. D; RISS, J. R; KRIEL, R. L et al.Acta neurologica scandinavica. 2009, Vol 120, Num 5, pp 353-357, issn 0001-6314, 5 p.Article

Methods to Account for Inaccuracies in the Dosing History When Performing Population Pharmacokinetic AnalysisPAVAN KUMAR, Venkata V; DUFFULL, Stephen B.Pharmaceutical research. 2008, Vol 25, Num 12, pp 2740-2749, issn 0724-8741, 10 p.Article

Physiologically Based Pharmacokinetic (PBPK) Modeling in ChildrenBARRETT, J. S; DELLA CASA ALBERIGHI, O; LÄER, S et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 1, pp 40-49, issn 0009-9236, 10 p.Article

Enhancing bioavailability and hepatoprotective activity of andrographolide from Andrographis paniculata, a well-know medicinal food, through its herbosomeMAITI, Kuntal; MUKHERJEE, Kakali; MURUGAN, Venkatesh et al.Journal of the science of food and agriculture. 2010, Vol 90, Num 1, pp 43-51, issn 0022-5142, 9 p.Article

Pharmacokinetic/pharmacodynamic relationships: Basic conceptsTROCONIZ, I. F.Methods and findings in experimental and clinical pharmacology. 2002, Vol 24, pp 125-126, issn 0379-0355, 2 p., SUPDConference Paper

The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analysesVRIJENS, Bernard; GROSS, Robert; URQUHART, John et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 225-227, issn 1742-7835, 3 p.Article

Comparative Assessment of Empirical and Physiological Approaches on Predicting Human ClearancesTAMAKI, Sekihiro; KOMURA, Hiroshi; KOGAYU, Motohiro et al.Journal of pharmaceutical sciences. 2011, Vol 100, Num 3, pp 1147-1155, issn 0022-3549, 9 p.Article

Pharmacokinetic models for propofol―defining and illuminating the devil in the detailABSALOM, A. R; MANI, V; DE SMET, T et al.British journal of anaesthesia. 2009, Vol 103, Num 1, pp 26-37, issn 0007-0912, 12 p.Article

A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancerCHEETI, Sravanthi; BUDHA, Nageshwar R; RAJAN, Sharmila et al.Biopharmaceutics & drug disposition. 2013, Vol 34, Num 3, pp 141-154, issn 0142-2782, 14 p.Article

The Effects of Ethanol on the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Ezogabine (Retigabine)CREAN, Christopher S; TOMPSON, DebraJ.Clinical therapeutics. 2013, Vol 35, Num 1, pp 87-93, issn 0149-2918, 7 p.Article

A pharmacokinetic-pharmacodynamic model for neuromuscular blocking agents to predict train-of-four twitchesELEVELD, Douglas J; DE HAES, Ann; PROOST, Johannes H et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2003, Vol 30, Num 2, pp 105-118, issn 1567-567X, 14 p.Article